How to buy Annovis Bio stock

Annovis Bio, Inc is a biotechnology business based in the US. Annovis Bio shares (ANVS) are listed on the NYSE MKT and all prices are listed in US Dollars. Annovis Bio employs 2 staff and has a market cap (total outstanding shares value) of USD$194.6 million.

How to buy shares in Annovis Bio

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Annovis Bio. Find the stock by name or ticker symbol: ANVS. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Annovis Bio reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Annovis Bio, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Annovis Bio. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Our top pick for

Beginners

Robinhood

Our top pick for

Building a portfolio

Sofi Invest

Our top pick for

Advanced traders

Interactive Brokers

How we chose our top picks

We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.

• Our pick for beginners. We chose Robinhood for this category because it offers commission-free trading and is easy to use. You can search for stocks by company name, and the mobile app is clean and intuitive to use.
• Our pick for building a portfolio. We chose SoFi for this category because it offers both commission-free stocks and a free robo-advisor. That means you can open an active investing account to pick and choose companies you want to invest in, and open a robo-advisor account to help you build a portfolio and manage how much risk you take on.
• Our pick for active traders. We picked Interactive Brokers for this category because it offers advanced tools and low fees for active investors and pros. The simpler IBKR Lite platform is aimed at less-active investors, but all users older than 21 must meet a $20,000 liquid net worth requirement for a cash account.

What's in this guide?

1. ANVS shares summary
2. Compare share dealing platforms
3. Is ANVS stock a buy or sell?
4. Stock performance over time
5. Can I short ANVS shares?
6. Annovis Bio's financials
7. Does Annovis Bio pay a dividend?
8. Other common questions

Annovis Bio share price

Use our graph to track the performance of ANVS stocks over time.

Annovis Bio shares at a glance

• Key figures

Information last updated 2021-02-24.

52-week range	USD$2.42 - USD$34.2
50-day moving average	USD$15.0509
200-day moving average	USD$7.6862
Wall St. target price	USD$16
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.1626

Buy Annovis Bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Sort by:

Name	Product	Stock trade fee	Asset types	Option trade fee	Annual fee	Signup bonus
Robinhood		$0	Stocks, Options, ETFs, Gold/Commodities	$0	0%	Free stock (chosen randomly with a value anywhere between $2.50 and $200) Sign up using the "go to site" link	Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.	Go to site More Info		loading Fetching your data...
Interactive Brokers		$0	Stocks, Bonds, Options	$0 + $0.65/contract, $1 minimum	0%	N/A	IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.	Go to site More Info		loading Fetching your data...
Tastyworks		$0	Stocks, Options, Cryptocurrency	Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg Futures: $2.50/contract to open, $0 to close	0%	Get 100 shares of stock (worth $1 to $6 a share) Open and fund a new cash or margin account with $2,000+	Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.	Go to site More Info		loading Fetching your data...
Moomoo		$0 for US stocks	Stocks, Options, ETFs	$0		N/A	Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.	Go to site More Info		loading Fetching your data...
TradeStation		$0	Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency	$0 + $0.50/contract		$50 Deposit qualifying assets of $5,000+	A platform built for all kinds of traders and all styles of trading	Go to site More Info		loading Fetching your data...

loading

Compare up to 4 providers

Clear selection

Compare

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Annovis Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Annovis Bio, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Shorting Annovis Bio shares

There are currently 41,187 Annovis Bio shares held short by investors – that's known as Annovis Bio's "short interest". This figure is 28.3% down from 57,451 last month.

There are a few different ways that this level of interest in shorting Annovis Bio shares can be evaluated.

Annovis Bio's "short interest ratio" (SIR)

Annovis Bio's "short interest ratio" (SIR) is the quantity of Annovis Bio shares currently shorted divided by the average quantity of Annovis Bio shares traded daily (recently around 98064.285714286). Annovis Bio's SIR currently stands at 0.42. In other words for every 100,000 Annovis Bio shares traded daily on the market, roughly 420 shares are currently held short.

However Annovis Bio's short interest can also be evaluated against the total number of Annovis Bio shares, or, against the total number of tradable Annovis Bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Annovis Bio's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Annovis Bio shares in existence, roughly 10 shares are currently held short) or 0.0095% of the tradable shares (for every 100,000 tradable Annovis Bio shares, roughly 10 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Annovis Bio.

Find out more about how you can short Annovis Bio stock.

Annovis Bio overview

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. Its lead compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndrome, and other chronic neurodegenerative disorders. The company is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. Annovis Bio, Inc. was founded in 2008 and is based in Berwyn, Pennsylvania.

Frequently asked questions

• What percentage of Annovis Bio is owned by insiders or institutions?

  Currently 40.647% of Annovis Bio shares are held by insiders and 11.917% by institutions.

• How many people work for Annovis Bio?

  Latest data suggests 2 work at Annovis Bio.

• When does the fiscal year end for Annovis Bio?

  Annovis Bio's fiscal year ends in December.

• Where is Annovis Bio based?

  Annovis Bio's address is: 1055 Westlakes Drive, Berwyn, PA, United States, 19312

• What is Annovis Bio's ISIN number?

  Annovis Bio's international securities identification number is: US03615A1088

• What is Annovis Bio's CUSIP number?

  Annovis Bio's Committee on Uniform Securities Identification Procedures number is: 03615A108